台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-凱基-長庚 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-長庚 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1400.00142.7042.60-1382-0.26%
2024/12/2000.00142.6542.65-1464-0.22%
2024/12/1700.00143.0042.50-1573-0.17%
2024/12/16143.2500.0042.3515850.17%
2024/12/10144.7000.0043.6515940.17%
2024/12/06144.7000.0044.1516110.16%
2024/11/27144.7000.0044.2016550.15%
2024/11/2100.000.245.6545.65-0.2671-0.03%
2024/11/180.344.2000.0044.100.36990.04%
2024/11/1100.00248.7548.35-2731-0.27%
2024/10/28455.45253.3052.6027560.26%
2024/09/30154.8000.0054.4011,0460.10%
2024/09/205.155.14754.7155.00-1.91,023-0.18%
2024/09/19255.803.355.6253.20-1.3995-0.13%
2024/09/1800.00252.3052.30-2943-0.21%
2024/09/13247.8500.0047.8029670.21%
2024/09/0300.00151.3051.40-11,007-0.10%
2024/08/26150.5000.0049.6519710.10%
2024/08/1500.00147.3049.60-1917-0.11%
2024/08/070.351.60351.1050.70-2.7856-0.32%
2024/08/06149.0000.0049.0018410.12%
2024/08/0100.00555.7255.40-5804-0.62%
2024/07/3000.00256.3056.00-2794-0.25%
2024/07/26255.0000.0054.5027760.26%
2024/07/23253.5000.0054.1027700.26%
2024/07/19460.4500.0058.1047350.54%
2024/07/18762.06158.9062.2066580.91%
2024/07/17457.08257.6558.9025430.37%
2024/07/16156.4000.0057.2014270.23%
2024/07/11143.0000.0043.0013180.31%
2024/06/26146.15148.7548.7502880.00%
2024/06/24345.75345.5045.5002620.00%
2024/06/21446.50445.6945.2002580.00%
2024/06/2000.00247.6047.60-2250-0.80%
2024/06/19344.20447.0447.95-1224-0.44%
2024/06/18745.12544.0044.0022130.94%
2024/06/17145.3000.0045.3511870.53%
2024/05/1300.00141.3041.00-1180-0.55%
2024/04/15042.6500.0042.3001870.00%
2024/04/09144.2000.0043.5511910.52%
2024/03/26343.5700.0043.0532021.48%
2024/03/25044.3500.0044.5002010.00%
2024/03/20043.0000.0041.5501980.00%
2024/03/13143.0000.0042.6012090.48%
2024/03/12044.0000.0043.6002140.00%
2024/03/11042.8000.0042.6502230.00%
2024/02/22146.2000.0045.2513980.25%
2024/02/15146.4500.0046.0014360.23%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音